According to a recently published report by Roots Analysis, ongoing technological advancements, and emergence of precision medicine, is driving the proteomics market growth
The global proteomics market is expected to grow at a CAGR of 10.5%, in the forecast period 2024-2035; reaching $94.7 billion by 2035.
Proteomics, a part of “multi-omics”, refers to the large-scale study of proteins and their interactions within the cell. It provides unparalleled insights into cellular processes, disease mechanisms, and potential therapeutic targets by mapping the complex protein networks and understanding their functions. Proteomics has various applications in multiple sectors, including early disease diagnosis, drug discovery, personalized medicines, drug target identification, biomarker identification and validation, and many more. Interestingly, the advancements in mass spectrometry and bioinformatics have significantly enhanced the processing and interpretation of large omics datasets, thereby generating meaningful and reproducible insights. Moreover, the rising prevalence of chronic diseases has led to a notable surge in the adoption of proteomics solutions for biomarker research. Therefore, owing to the continuous technological advancements in the domain, coupled with the rise in demand for proteomics solutions, the proteomics market value is poised to experience noteworthy increase during the forecast period.
Browse ~125 figures and ~105 market data tables spread across ~235+ slides and detailed Table of Content on “Proteomics Market: Industry Trends and Global Forecasts, till 2035, by Type of Offering, Type of Instrument / Technology, Type of Reagent, Type of Proteomics Service, Application Area, End Users, and Geography” here: https://www.rootsanalysis.com/reports/proteomics-market.html
Several factors are propelling the proteomics market growth. One of the key factors driving the future of proteomics market is the continuous technological advancements in mass spectrometers (such as introduction of 4D proteomics) and bioinformatics (such as improved computational tools driven by AI and machine learning). These advancements are optimizing the proteomics workflow and are providing a competitive edge to the players in the proteomics market. In addition, the emergence of personalized medicines has demonstrated the potential of proteomics in offering comprehensive insights into a particular expressed protein. Further, considering the increasing pace of innovation, funding and research activity in this domain, the proteomics market is anticipated to witness a steady growth in the foreseen future.
While the proteomics market is experiencing substantial growth, there are various restraints that can hinder the growth of the industry. One of the primary restraints in this domain is the high cost involved in maintaining well-equipped facilities, integrating sophisticated technologies and advanced instruments, such as nano-proteomics tools, chromatography systems and mass spectrometers. Secondly, companies which lack technological know-how may struggle to optimize the proteomics workflow techniques, which can limit its adoption and scalability. Further, achieving reproducibility and standardization in proteomics is associated with several challenges due to the variability in sample preparation, data acquisition and analytical techniques, which often leads to inconsistent results, thereby impacting the reliability of proteomic studies and its widespread adoption.
Despite the challenges and various market restraints, several factors continue to drive the proteomics market growth. Interestingly, the advent of nano-proteomics (to analyze protein in smaller cell populations and single cells) is enhancing sensitivity, throughput and preciseness of protein analysis. In addition, proteomic biomarker techniques are now being utilized in handheld diagnostic devices, leading to the emergence of point-of-care diagnostics for rapid disease detection. Moreover, as chronic diseases, such as cancer, heart disease, and diabetes continue to become more prevalent, there is an increasing demand for advanced proteomics research to discover biomarkers that can aid in early disease detection. Further, the integration of multi-omics has witnessed tremendous growth in the field of research, providing a more holistic view of novel biological systems and disease pathogenesis.
The proteomics market report also includes profiles of key players (listed below) that offer proteomics solutions:
You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/proteomics-market/request-sample.html
Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner
SUBSCRIBE TO INDUSTRY UPDATES